z-logo
open-access-imgOpen Access
An Alternative Surgical Technique of Native Hepatectomy in Liver Transplantation
Author(s) -
Maogen Chen,
Weiqiang Ju,
Xiaohong Lin,
Yinghua Chen,
Qiang Zhao,
Zhiyong Guo,
Xiaoshun He,
Dongping Wang
Publication year - 2021
Publication title -
annals of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.494
H-Index - 38
eISSN - 2329-0358
pISSN - 1425-9524
DOI - 10.12659/aot.929259
Subject(s) - medicine , liver transplantation , hepatectomy , surgery , anastomosis , inferior vena cava , transplantation , alanine transaminase , orthotopic liver transplantation , liver disease , liver function , resection
Background Orthotopic liver transplantation has become the procedure of choice for end-stage liver disease. There are 3 commonly used methods of vena cava anastomosis. Here, we report a new technique for native hepatectomy. Material/Methods The data of 12 patients who underwent orthotopic liver transplantation using a new surgical technique were retrospectively collected for analysis. The new separation and reconstruction surgical technique mainly involved the second portal isolation and hepatectomy that followed. We performed recipient liver resection without the occlusion of the inferior vena cava, which was then followed by classic, piggyback, modified piggyback, or side-to-side orthotopic liver transplantation. The graft function index and complications were collected after transplantation. Results The length of the anhepatic phase was 30.92±9.1 min. Alanine transaminase (ALT) levels were 138 to 2027 U/L, with a median of 361.5 U/L. The ALT levels of all patients gradually decreased to normal levels 7 to 10 days after surgery. Only 2 recipients had elevated levels of ALT higher than 1000 U/L. Four of 12 patients did not require red blood cell transfusion during surgery. Four patients appeared to have early allograft dysfunction, while others recovered smoothly. Conclusions This new surgical technique may shorten the anhepatic phase and decrease blood loss volume, aiding the success of liver transplant surgery. It can be used for most patients and does not increase the risk of complications or impair prognosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom